VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $483,000 | +40.4% | 20,794 | -3.7% | 0.26% | +18.6% |
Q1 2018 | $344,000 | +0.9% | 21,594 | +31.7% | 0.22% | -6.8% |
Q4 2017 | $341,000 | +100.6% | 16,394 | +37.8% | 0.24% | +82.3% |
Q3 2017 | $170,000 | -17.5% | 11,894 | 0.0% | 0.13% | -29.0% |
Q2 2017 | $206,000 | +50.4% | 11,894 | -4.0% | 0.18% | +84.8% |
Q1 2017 | $137,000 | -23.9% | 12,394 | 0.0% | 0.10% | -19.5% |
Q4 2016 | $180,000 | – | 12,394 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |